Neomics Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -79.21%
- Profit Growth -4483.18%
- Ebitda 44.51%
- Net Worth -203.66%
- Total Assets -42.56%
About Neomics Research Foundation
Neomics Research Foundation (NRF) is a Private Not For Profit Company incorporated in India on 14 February 2014 and has a history of 11 years. Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anjali Netraranjn, Alben Sigamani, and Anjali Choudhury serve as directors at the Company.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100AS2014NPL011785
-
Company No.
011785
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
14 Feb 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Neomics Research Foundation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Netraranjn
|
Additional Director | 31-Oct-2023 | Current |
|
Alben Sigamani
|
Additional Director | 31-Oct-2023 | Current |
|
Anjali Choudhury
|
Director | 20-Dec-2019 | Current |
Financial Performance of Neomics Research Foundation.
Neomics Research Foundation, for the financial year ended 2017, experienced significant reduction in revenue, with a 79.21% decrease. The company also saw a substantial fall in profitability, with a 4483.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 203.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neomics Research Foundation?
In 2017, Neomics Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Carmel Research Consultancy Private LimitedAlben Sigamani is a mutual person
-
Exactitude Medical Foundation
Alben Sigamani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neomics Research Foundation?
Unlock and access historical data on people associated with Neomics Research Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neomics Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neomics Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
